Data di Pubblicazione:
2006
Citazione:
Medical management of endometriosis / L. Fedele, S. Bianchi, E. Fontana, N. Berlanda, G. Frontino, A. Bulfoni. - In: WOMEN'S HEALTH. - ISSN 1745-5057. - 2:2(2006 Mar), pp. 297-308. [10.2217/17455057.2.2.297]
Abstract:
Current approved medical therapies for endometriosis rely on drugs that suppress ovarian steroids and induce a hypoestrogenic state, which determines the atrophy of the ectopic endometrium. Gonadotropin-releasing hormone analogs such as danazol, progestogens and estrogen-progestin combinations have all proven effective in relieving pain and reducing the extent of endometriotic implants. However, symptoms often recur after discontinuation of therapy and hypoestrogenism-related side effects limit the long-term use of most medications. Recently, knowledge of the pathogenesis of endometriosis, particularly at the molecular level, has grown substantially, providing a rational basis for the development of new drugs with precise targets that may be safely administered over the long term.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
Amenorrhea; Dysmenorrhea; Dyspareunia; Endometriosis; Hormonal treatment; Medical treatment; Pelvic pain
Elenco autori:
L. Fedele, S. Bianchi, E. Fontana, N. Berlanda, G. Frontino, A. Bulfoni
Link alla scheda completa: